The MAP kinase p38a is essential for neuronal signaling. To better understand the molecular regulation of p38a we used atomistic and molecular techniques to determine the structural basis of p38a regulation by the two neuronal tyrosine phosphatases, PTPSL/PTPBR7 (PTPRR) and STEP (PTPN5). We show that, despite the fact that PTPSL and STEP belong to the same family of regulatory proteins, they interact with p38a differently and their distinct molecular interactions explain their different catalytic activities. Although the interaction of PTPSL with p38a is similar to that of the previously described p38a:HePTP (PTPN7) complex, STEP binds and regulates p38a in an unexpected manner. Using NMR and small-angle X-ray scattering data, we generated a model of the p38a:STEP complex and define molecular differences between its resting and active states. Together, these results provide insights into molecular regulation of p38a by key regulatory proteins.
INTRODUCTION
The mitogen-activated protein kinases (MAPKs) p38, ERK, and JNK are central to evolutionarily conserved signaling pathways that are present in all eukaryotic cells. Each MAPK cascade is activated in response to a diverse array of extracellular signals and culminates in the dual phosphorylation of a threonine and a tyrosine residue in the MAPK activation loop (Dé rijard et al., 1995) . Dually phosphorylated MAPKs then phosphorylate both cytosolic and nuclear targets, with the localization and duration of MAPK activity determining the cellular response to the initial extracellular signal. MAPK signal duration is finely controlled by multiple phosphatases, including three kinase interaction motif protein tyrosine phosphatases (KIM-PTPs): PTPSL/ PTPBR7 (PTPRR), STEP (PTPN5), HePTP (PTPN7 and LC-PTP) (Hendriks et al., 1995; Lombroso et al., 1991; Zanke et al., 1992) . KIM-PTPs control MAPK signaling by two mechanisms:
(1) the KIM-PTP binds to an unphosphorylated MAPK to sequester it in the cytosol (known as the resting-state complex); and (2) the KIM-PTP dephosphorylates and inactivates a phosphorylated MAPK (known as the active-state complex) (Tá rrega et al., 2002; Xu et al., 2009) .
Increasing evidence suggests a crucial role for MAPK signaling in the central nervous system (CNS), and aberrant phosphorylation within the CNS is associated with a multitude of neurological disorders, including Alzheimer's disease and Parkinson's disease (Kim and Choi, 2010) . Correspondingly, an additional layer of MAPK regulation is present within neurons. Two KIM-PTPs, PTPSL and STEP, are expressed within discrete regions of the CNS. PTPSL expression is highest in the cerebellum, while STEP is expressed in the hippocampus, striatum, amygdale, and cortex (Chirivi et al., 2004; Lombroso et al., 1993; Van Den Maagdenberg et al., 1999) . PTPSL, STEP, and the other KIM-PTP, HePTP, have a 17residue kinase interaction motif (KIM or D-motif) that is essential for their interaction with ERK2 and p38 (Blanco-Aparicio et al., 1999; Saxena et al., 1999) . The KIM binds to a conserved binding site that is formed by the hydrophobic docking groove and an acidic patch named the common docking (CD) site (together known as the KIM binding site or D-motif recruitment site) (Tá rrega et al., 2002; Zhou et al., 2006) . The KIM sequence is well conserved across the KIM-PTP family. All three KIMs contain basic residues, proposed to engage the CD site, upstream of a hydrophobic motif (L-X-L-X-F, where F is a methionine in STEP and PTPSL and a valine in HePTP; Figure 1A ). Previously, we used nuclear magnetic resonance (NMR) spectroscopy and isothermal titration calorimetry (ITC) to define the interface of HePTP KIM binding to p38a. We determined that the hydrophobic motif occupies three hydrophobic pockets within the p38a hydrophobic docking groove, while its basic residues interact with the acidic patch (Francis et al., 2011a) .
C terminal to the KIM is a region known as the kinase-specificity sequence (KIS), which is followed by a globular PTP catalytic domain (CAT) (Eswaran et al., 2006; Muñ oz et al., 2003; Mustelin et al., 2005) . Whereas the CAT is essential for dephosphorylation of the MAPK by the KIM-PTP, the importance of the KIS remains ambiguous, especially because the KIS sequence is divergent among the KIM-PTP family members. We previously showed that the HePTP KIS is highly flexible and contributes significantly to the interaction between HePTP and p38a, while HePTP CAT does not interact with unphosphorylated p38a. This was corroborated by small-angle X-ray scattering (SAXS) experiments that showed that the p38a:HePTP resting-state complex is elongated in solution (Francis et al., 2011a) . Whether the extensive KIS interaction, limited CAT interaction, and extended resting-state conformation observed in p38a:HePTP are common features of all p38a:KIM-PTP resting-state complexes is currently unknown.
Similar studies with a different MAPK, ERK2, revealed that the ERK2:HePTP resting-state complex shares several of these fea-tures. As with p38a, HePTP CAT does not interact with ERK2 in the resting state, and the ERK2:HePTP resting-state complex is extended in solution (Piserchio et al., 2012) . However, phosphorylation of ERK2 leads to a domain rearrangement in which HePTP CAT rotates by nearly 180 , the ERK2:HePTP complex compacts, and the HePTP catalytic site residue moves by $65 Å to allow for dephosphorylation of ERK2 (Francis et al., 2011b) . The flexibility of the HePTP KIS and the absence of an interaction between ERK2 and HePTP CAT are critical to facilitate this large rearrangement.
Here, we combined NMR spectroscopy, SAXS, ITC experiments, and HADDOCK modeling to delineate the interaction of (Larkin et al., 2007) . KIM residues are colored in orange and blue. KIS residues are colored in gray. p38a with STEP and PTPSL. In combination with experiments conducted with HePTP, these studies serve as a detailed atomic-level characterization of MAPK regulation by an entire family of regulators-the KIM-PTP family. Our results reveal key differences between the interactions of p38a with each KIM-PTP. We show that the interaction of p38a with PTPSL is closely related to the interaction of HePTP, whereas the interaction of p38a with STEP is quite different and includes an unexpected contribution from STEP CAT .
RESULTS

KIM Binding to p38a Is Conserved within the KIM-PTP Family
We used NMR spectroscopy to define the p38a binding interface of the STEP KIM and PTPSL KIM peptides (constructs used in this study are illustrated in Figure 1B ). Each peptide was individually titrated into [ 2 H, 15 N]-p38a until binding was saturated (1:1, 1:3, 1:5, 1:8 molar ratio of p38a:peptide) and two-dimensional (2D) [ 1 H, 15 N] TROSY spectra were recorded (Figures 1C and 1D; Figure S1A available online) . The fully saturated 2D [ 1 H, 15 N] TROSY spectra of p38a:PTPSL KIM and p38a:STEP KIM (100 mM [ 2 H, 15 N]-p38a:800 mM peptide) are highly similar ( Figure 1E ; Figure S1B ). All peak shifts are in fast exchange and can be readily followed with the exception of three peaks that map to the MAPK-specific insert (L262-Q264) and are broadened beyond detection independent of ligand ( Figure S1A ). As expected, both peptides caused significant chemical shift perturbations (CSPs) for residues located in the KIM binding site, including helix aD, helix aE, the aD-aE loop, the b7-b8 turn, loop 4, and the CD site ( Figure 2 ). Thus, like HePTP KIM , PTPSL KIM and STEP KIM engage all three hydrophobic pockets and interact with the acidic patch, demonstrating that the mode of KIM binding to p38a is conserved within the KIM-PTP family.
However, there are small differences among the CSPs induced by STEP KIM and PTPSL KIM . L164 in b8 exhibits the largest CSP difference among the 2D [ 1 H, 15 N] TROSY spectra of p38a:PTPSL KIM and p38a:STEP KIM ( Figure 1E ; Figure S1B ). The N-terminal residues of the KIM (Ile in PTPSL KIM ; Met in STEP KIM ) are the only residues not identical between the two peptides; therefore, any differences between the two spectra are a result of the differential interaction of this residue with p38a. Based on the structure of ERK2:HePTP KIM , this residue is immediately adjacent to the b7-b8 turn, further supporting our NMR results (Zhou et al., 2006) .
Although the KIM binding mode is conserved among the KIM-PTPs, the HePTP KIM sequence is only $75% conserved when compared with PTPSL KIM and STEP KIM ( Figure 1A ). This leads Histograms showing the combined 1 H/ 15 N CSP versus p38a residue for the following experiments: p38a with PTPSL KIM (1:8 molar ratio), PTPSL KIMKIS (1:3 molar ratio), PTPSL (1:1 ratio; SEC purified), STEP KIM (1:8 molar ratio), STEP KIMKIS (1:8 molar ratio), STEP (1:1 ratio; SEC purified), and PSChimera (1:1 ratio; SEC purified). Residues that form the p38a hydrophobic docking groove and the CD site are highlighted by blue and orange boxes, respectively. Residues with peak line widths broadened beyond detection upon titration are colored in green. See also Figure S3 .
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to changes in the chemical environment for residues within the p38a KIM binding site, which are readily observed in the 2D [ 1 H, 15 N] TROSY spectra ( Figure S1C ). PTPSL KIM and STEP KIM perturb nine more peaks than HePTP KIM (Francis et al., 2011a) . Compared to HePTP KIM , PTPSL KIM and STEP KIM interact differentially with several residues within the hydrophobic binding groove and loop 4, including N82, A111, L113, C119, L122, D124, D125, V127, L130, S154, E160, C162, and L164 (Figure 1E ). These NMR CSP experiments correspond well with ITC measurements that showed PTPSL KIM and STEP KIM bind p38a approximately two times tighter than does HePTP KIM (Table 1; Figure S2 ).
An NMR View of the Interaction between PTPSL and p38a
We expanded the NMR experiments to define the binding interface of PTPSL with p38a. In this experiment, [ 2 H, 15 N]-p38a was incubated with unlabeled PTPSL, the 78 kDa p38a:PTPSL complex was purified by size exclusion chromatography (SEC), and a 2D [ 1 H, 15 N] TROSY spectrum was immediately recorded ( Figure S3C ).
Direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of free and PTPSL-bound p38a reveals CSPs of 41 peaks, 36 in fast exchange and 5 peaks with line widths broadened beyond detection (N115, Q120, F129, L130, and S154; Figure 2 ). Like PTPSL KIM , PTPSL perturbed residues clustered within the hydrophobic binding groove and the acidic patch of p38a (Figure 2) . Two peaks, N115 (line widths broadened beyond detection) and V127, are perturbed by full-length PTPSL but not by PTPSL KIM , with additional peaks experiencing larger CSPs (G110, D112, I116, K118, Q120, and Q310) ( Figure 2 ). Correspondingly, full-length PTPSL binds approximately seven times tighter to p38a than does PTPSL KIM (Table 1; Figure S2 ).
The majority of the additional CSPs map to a region of p38a that interacts with HePTP KIS (Francis et al., 2011a) . Although the PTPSL KIS and HePTP KIS sequences are only $50% conserved, this region of p38a is thus also likely interacting with PTPSL KIS . To determine whether a peptide composed of the PTPSL KIM and PTPSL KIS sequences (i.e., PTPSL KIMKIS ) can recapitulate the binding of full-length PTPSL to p38a, we titrated the PTPSL KIMKIS into [ 2 H, 15 N]-p38a, and a series of 2D [ 1 H, 15 N] TROSY spectra were recorded ( Figure S3B ). Titra-tion of a three-fold molar excess of the PTPSL KIMKIS peptide (100 mM [ 2 H, 15 N]-p38a:300 mM PTPSL KIMKIS ) resulted in a nearly identical 2D [ 1 H, 15 N] TROSY spectrum as that of p38a:PTPSL (Figure 2 , Figure S3H ). Differences include residues N115 and S154, which are broadened beyond detection by full-length PTPSL but are either not perturbed (N115) or undergo a large CSP (S154) with PTPSL KIMKIS , respectively ( Figure S3H ). Furthermore, a direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of p38a:PTPSL KIM with p38a:PTPSL-KIMKIS shows larger CSPs for four residues (M109, K118, E160, and L164), and three peaks (Q120, F129, and L130) are broadened beyond detection by PTPSL KIMKIS but not by PTPSL KIM (Figure S3H ). Consistent with these results, the PTPSL KIMKIS binds p38a approximately two times tighter than does PTPSL KIM (Table 1 ; Figure S2 ).
The p38a:PTPSL Resting-State Complex Is Extended in Solution
The interactions of PTPSL KIM , PTPSL KIMKIS , and PTPSL with p38a are highly similar. PTPSL perturbed few residues outside of the KIM binding site, confirming that the KIM is the essential anchor for the interaction of PTPSL with p38a. Indeed, we used NMR spectroscopy to probe the interaction of p38a with PTPSL CAT , a construct lacking residues 332-360, which includes the KIM; no interactions between p38a and isolated PTPSL CAT were detected ( Figures S4A and S4C ). This is consistent with previous results from NMR experiments that showed that the isolated HePTP CAT did not interact with either p38a or ERK2 (Francis et al., 2011a; Piserchio et al., 2012) .
Consequently, we used SAXS to determine the size and shape of the p38a:PTPSL resting-state complex. The p38a:PTPSL complex was purified by SEC, and SAXS data were recorded at Beamline X9A at the National Synchrotron Light Source (Brookhaven National Laboratories). Using the Guinier approximation of five independent SAXS samples, a radius of gyration (R g ) of 33.1 ± 0.5 Å was calculated for the p38a:PTPSL complex (Table 2; Figure 3A ). A maximum particle dimension (D max ) of 105 Å was determined by analysis of the P(r) function (Table 2; Figures 3D  and 3E) . These values for R g and D max are highly similar to those determined for the p38a:HePTP and ERK2:HePTP resting-state complexes and demonstrate that, under resting conditions, p38a and PTPSL adopt an extended conformation, with a rather 
Structure MAPK:KIM-PTP Complexes limited interaction surface, consistent with the NMR CSP experiments.
The p38a:STEP Resting-State Complex Is Compact An equivalent SAXS measurement was performed for the p38a: STEP resting-state complex. The Guinier approximation of four independent SAXS samples was used to calculate an R g of 29.9 ± 0.3 Å , showing that the R g of the p38a:STEP resting-state complex is $3.0 Å smaller than that of the p38a:PTPSL and p38a:HePTP resting-state complexes (Table 2; Figure 3B ). To analyze this difference in more detail, we determined the molecular envelope of the p38a:STEP resting-state complex (Table 2 ; Figures 3D and 3F) . A D max of 95 Å was determined by analysis of the P(r) function, which is $10-15 Å shorter than the p38a:PTPSL and p38a:HePTP complexes (Table 2; Figure 3D ). Thus, the p38a:STEP resting-state complex is more compact than both the p38a:KIM-PTP and the ERK2:HePTP resting-state complexes. Therefore, unlike PTPSL and HePTP, which have limited interaction surfaces with p38a, this result suggested that STEP may interact more extensively with p38a.
STEP Has Interactions with p38a Outside of the KIM Binding Pocket
To test this hypothesis, we performed NMR CSP experiments with full-length STEP and [ 2 H, 15 N]-p38a. Here, [ 2 H, 15 N]-p38a was incubated with unlabeled STEP, the 78 kDa p38a:STEP complex purified by SEC, and a 2D [ 1 H, 15 N] TROSY spectrum recorded ( Figure S3F ). Direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of free and STEP-bound p38a reveals CSPs of 58 peaks, 40 in fast exchange and 18 with peak line widths that are broadened beyond detection ( Figure 2 ). As expected, like STEP KIM , STEP perturbs residues in the p38a KIM binding site ( Figure 2) . Surprisingly, STEP perturbed significantly more residues in p38a than did STEP KIM and caused several additional peaks to broaden beyond detection, decreasing the total number of peaks in the 2D [ 1 H, 15 N] TROSY spectrum of STEP-bound p38a (Figure 2 ). Direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of p38a:STEP KIM and p38a:STEP reveals three additional residues (V30, M109, and L164) with CSPs and 18 additional peaks (D125, V127, Y132, I141, S154, D177, M179, V183, A190, Q202, R220, L222, L247, K248, S254, R256, H312, and E328) that are broadened beyond detection by full-length STEP ( Figure S3I ). Correspondingly, full-length STEP binds approximately six times tighter to p38a than does STEP KIM (Table 1 ; Figure S2 ). Mapping the additional perturbations reveals a previously undetected p38a interaction surface (herein referred to as the PTP site), which connects the p38a activation loop to the MAPK-specific insert.
To corroborate our findings, we used a divide and conquer approach. To determine whether the STEP KIS accounts for this additional interaction, a peptide composed of the STEP KIMKIS sequence was titrated into [ 2 H, 15 N]-p38a, and a series of 2D [ 1 H, 15 N] TROSY spectra was recorded ( Figure S3E ). Interestingly, the p38a:STEP KIMKIS spectrum (100 mM [ 2 H, 15 N]-p38a:800 mM STEP KIMKIS ) is similar to that of p38a:STEP KIM at the same molar ratio (Figure 2 ; Figure S3I ). Direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of p38a:STEP KIM and p38a: STEP KIMKIS reveals differences in seven residues: V30, M109, and E160 show CSPs, while G85, D125, V127, and S154 are broadened beyond detection ( Figure S3I ). Using ITC, we determined that STEP KIMKIS binds approximately two and a half times tighter than does STEP KIM but two times weaker than full-length STEP does (Table 1; Figure S2 ). Importantly, the STEP KIMKIS did not affect residues within the PTP site ( Figure 2 ). This suggests that the additional changes in the NMR spectrum must be the result of an interaction between the STEP catalytic domain (STEP CAT ) and p38a.
p38a:PSChimera Complex
To confirm that STEP CAT interacts directly with p38a, we generated a chimeric protein in which PTPSL KIMKIS was fused with STEP CAT (herein referred to as the PSChimera; Figure 1B ). The PSChimera was expressed, purified, and incubated with [ 2 H, 15 N]-p38a. The p38a:PSChimera complex was then purified by SEC, and a 2D [ 1 H, 15 N] TROSY spectrum of the complex was recorded ( Figure S3G ).
Within and around the p38a KIM binding site, the PSChimera affected the p38a 2D [ 1 H, 15 N] TROSY spectrum in a PTPSL-like manner ( Figure 2) . Notably, additional changes in the p38a 2D [ 1 H, 15 N] TROSY spectrum, which correspond to peaks that define the PTP site, were also identified ( Figure 2) . Thus, the PSChimera, which has a PTPSL KIMKIS and a STEP CAT domain, interacts in a PTPSL-like manner with its KIMKIS and in a STEP-like manner at the PTP site. Minor differences between the interaction of the PSChimera and STEP with p38a at the PTP site include Q202 and K248, which are not broadened beyond detection with PSChimera (K248 does experience a small CSP). Similar to STEP, 17 peaks in the PTP site broaden beyond detection with PSChimera, demonstrating that the STEP CAT interaction with p38a is independent of the KIMKIS sequence. Furthermore, NMR interaction studies showed that titration of unlabeled, isolated STEP CAT (lacking residues 214-243 including the KIM) with [ 2 H, 15 N]-p38a results in nonspecific interactions throughout the p38a surface-further reinforcing the critical importance of KIM anchoring for p38a regulation (Figures S4B and S4C) . The chimeric protein has a slightly higher binding affinity than does PTPSL or STEP for p38a (Table 1) . This binding affinity is the product of the PTPSL KIM , which binds the tightest of the three KIM-PTP KIM peptides, coupled with the additional binding strength afforded by the STEP CAT interaction. 
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Defining the p38a Binding Site on STEP To define the p38a binding interface on STEP, we performed reverse NMR experiments with [ 2 H, 15 N]-STEP and unlabeled p38a. We previously published the sequence-specific backbone assignments of STEP CAT (Francis et al., 2013) . The 2D [ 1 H, 15 N] TROSY spectrum of STEP contains 30 additional peaks when compared to that of STEP CAT, in agreement with the 31 additional N-terminal residues in STEP ( Figure S4D ). All new peaks cluster around $8.0 ppm, a chemical shift range typical for unstructured residues, suggesting that the KIM and KIS regions of STEP are unstructured in the unbound state, identical to what we have seen for HePTP ( Figure S4D ) (Francis et al., 2011a) . Last, the vast majority of peaks in the STEP 2D [ 1 H, 15 N] TROSY spectrum overlap perfectly with peaks in the STEP CAT 2D [ 1 H, 15 N] TROSY spectrum, showing that the flexible N-terminal residues in STEP do not interact with STEP CAT . This allowed for the transfer of the STEP CAT sequence-specific backbone assignment to STEP. Peaks corresponding to residues 244-253, the majority of helix a0, have very different chemical shifts between STEP and STEP CAT , indicating that the presence of the flexible N terminus (residues 214-243) alters the chemical environment of residues 244-253. This is consistent with what was observed for HePTP, in which helix a0 (residues 44-56) was also perturbed by the presence of the N terminus, residues 15-43 (Francis et al., 2011a) . Previously, it was hypothesized that helix a0 must change conformation for the regulatory Ser/Thr residue at the N terminus of the helix to be phosphorylated (Mustelin et al., 2005; Szedlacsek et al., 2001) . These NMR studies show that this hypothesis is correct and the pliability of helix a0 is conserved within the KIM-PTP family. To test the effects of p38a binding on STEP, the complex between [ 2 H, 15 N]-STEP and unlabeled p38a was purified by SEC, and a 2D [ 1 H, 15 N] TROSY spectrum of the 78 kDa complex was immediately collected ( Figure S4E ). Direct comparison of the 2D [ 1 H, 15 N] TROSY spectra of free and p38a-bound STEP reveals changes in 54 peaks, 22 of which are in fast exchange and 32 with peak line widths broadened beyond detection ( Figure 4A ; Figure S4E ). Included in this total are 21 of the new peaks that clustered around 8.0 ppm in the free STEP spectrum that are broadened beyond detection or overlap with other peaks in the 2D [ 1 H, 15 N] TROSY spectrum of the p38a:STEP complex. This indicates, as expected, a strong involvement of the STEP KIM in p38a binding. Additional new peaks unperturbed by p38a binding originate from STEP KIS residues that do not contribute to p38a binding. Thirty-three perturbed peaks are in STEP CAT , including residues in helix a1 0 (A263, E268, and K269), helix a2 0 (F274, L276, E277, A278, E279, F280, F281, and E282), the b4-b7 loop (N376, I377, E378, E379, and M380), helix a4 (R478, T479, and F482), and helix a6 (T517, C518, Q520, and H525) ( Figure 4A ). Other STEP CAT residues that are affected include L254, A257, M285, N286, D294, T306, I307, G350, V353, and the catalytically important Q516 ( Figure 4A ).
3D Model of the p38a:STEP Complex
We used the NMR data, which describe the interaction interface of STEP on p38a and vice versa, together with surface accessibility data to restrain the docking of STEP and p38a using HADDOCK (the crystal structures of apo-p38a [1P38] and STEP CAT Eswaran et al., 2006; Wang et al., 1997] were used as starting structures). Although the STEP CAT structure does not include STEP KIMKIS residues (214-257), we have establishedusing the PSChimera-that the STEP CAT interaction occurred independent of a specific KIMKIS sequence. Consequently, only p38a residues affected by STEP CAT in both STEP and the PSChimera were used as input for the HADDOCK calculations. The lowest energy cluster produced by HADDOCK contained 76 structures with a root-mean-square deviation of 0.8 Å . The four lowest energy structures from this cluster are shown in Figure 4B . In all HADDOCK models, STEP helix a2 0 binds to p38a between the activation loop and the MAPK-specific insert. The interface between the two proteins buries 2,125 ± 116 Å 2 of surface area. To experimentally test the validity of the model, we compared the calculated (determined using Hydropro; Ortega et al., 2011) R g of the lowest energy p38a:STEP HADDOCK model (R g = 29.2 Å ) with the experimentally determined R g (R g = 29.9 Å ). The excellent consistency of the R g s is further supported by the excellent fit of the lowest energy p38a:STEP HADDOCK model into the molecular envelope determined for the p38a:STEP resting-state complex (NSD = 1.7; Figure 4C ). Additionally, modeling the KIM peptide into the KIM binding site of p38a (based on the ERK2:HePTP KIM crystal structure; Zhou et al., 2006) results in, as expected, a further improved model of the p38a:STEP resting-state complex (R g = 30.1 Å ; D max = 92 Å ). This model, which comprises every component of the complex but the STEP KIS , superimposes even better with the p38a:STEP molecular envelope (NSD = 1.5; Figure 4C ) (Kozin and Svergun, 2001) .
To further verify the model of the p38a:STEP resting-state complex, we generated a number of STEP mutants that are predicted to lead to changes in binding affinity because the mutated residues are directly involved in the p38a:STEP interaction. Indeed, mutation of residue F281 in helix a2 0 , and to a lesser Structure extent M285 and I307, showed a reduction of the binding affinity, clearly showing that helix a2 0 is important for the interaction of STEP with p38a and further confirming the HADDOCK model (Table 1 ).
The p38a:STEP Active-State Complex
We have shown that STEP CAT , when tethered via the KIM, interacts with p38a and perturbs residues in the p38a activation loop. However, this does not imply that STEP is poised and ready to efficiently dephosphorylate p38a. In fact, in the HADDOCK p38a:STEP resting-state complex model the STEP active site cysteine is $35 Å away from the p38a phosphorylation loop tyrosine. Therefore, a domain arrangement must occur between the resting and active states of the p38a:STEP complex to properly position STEP CAT for dephosphorylation of p38a.
To verify that a domain rearrangement occurs between the active and resting states of the p38a:STEP complex, we used SAXS to determine the size and shape of the p38a:STEP active-state complex (Akella et al., 2010; Nielsen and Schwalbe, 2011) . p38a was dually phosphorylated in vitro using a constitutively active mutant of MKK6. Phosphorylated p38a was incu-bated with a substrate-trapping mutant of STEP (C472S/ T306D), the complex purified by SEC, and SAXS data recorded ( Figure 5A ). Using the Guinier approximation of six independent SAXS samples, an R g of 28.5 ± 0.3 Å was calculated for the p38a:STEP active-state complex (Table 2; Figure 5A ). This R g is 1.5 Å smaller than the R g of the resting-state complex. More striking, the D max of the active-state complex, 80 Å , is 15 Å shorter than the resting-state complex ( Table 2 ; Figures 5C  and 5D ). These data show that the p38a:STEP active-state complex is more compact than the resting-state complex and support that a domain rearrangement occurs between the resting and active states of the p38a:STEP complex. Thus, although STEP CAT interacts with p38a in the resting state, it is not properly positioned for dephosphorylation of p38a.
DISCUSSION
Our current understanding of MAPK regulation by their regulatory proteins at the molecular level is extremely limited because these essential signaling complexes have proven exceedingly difficult to investigate using traditional structural Structure MAPK:KIM-PTP Complexes approaches. Years of efforts to crystallize MAPK:KIM-PTP complexes have not been successful, and their large molecular weights, $80 kDa, make NMR analysis onerous. To circumvent these problems, we examined the binding of each domain of STEP and PTPSL to p38a using NMR CSP and ITC experiments and then determined the overall molecular shape of the complexes using SAXS. Using this approach, we show that, despite having similar KIM-peptide interactions and overall binding affinities with p38a, the p38a:PTPSL and p38a:STEP resting-state complexes are surprisingly different as a result of an additional interaction of the STEP catalytic domain with p38a. These studies, in combination with complementary studies previously performed between p38a and HePTP, provide a detailed investigation of MAPK regulation by an entire family of regulators (Francis et al., 2011a) .
Using NMR experiments, we show that the mode of KIM binding to p38a is conserved among the KIM-PTP family. Uniformly, PTPSL KIM , STEP KIM , and HePTP KIM engaged residues within the three hydrophobic pockets and perturbed residues at the CD site. In contrast, crystal structures of p38a bound to KIM peptides of the activating kinases, MKK3b and MKK6, reveal a different mode of binding in which only hydrophobic pockets F A and F B are engaged and an extensive electrostatic interaction with the CD site is absent (Chang et al., 2002; Garai et al., 2012) . This demonstrates a critical point in MAPK selectivity; the mechanism of KIM binding to p38a is different for each class of regulators (i.e., MAPKKs versus KIM-PTPs).
Based on NMR and SAXS data, the interaction of resting-state p38a with PTPSL is similar to that described previously between p38a and HePTP. However, the p38a:PTPSL and p38a:HePTP interactions are not identical. One key feature of the p38a:HePTP interaction, the extensive interaction between p38a and the HePTP KIS , is not observed between p38a and the PTPSL KIS (Francis et al., 2011a) . Despite the limited interaction surface between p38a and PTPSL, PTPSL binds p38a nearly six times tighter than HePTP does. Recently published in vitro phosphatase assays showed that although HePTP and PTPSL can both readily dephosphorylate p38a, PTPSL is the most efficient p38a phosphatase of all tested (Zhang et al., 2011) . This is likely the product of (1) the highest affinity interaction with p38a among the KIM-PTPs and (2) the limited interaction outside of the KIM, imposing minimal constraints on the flexibility and movement of the PTPSL CAT .
In contrast, the p38a:STEP resting-state complex is more compact than the other two p38a:KIM-PTP resting-state complexes because of an additional previously unidentified interaction between STEP CAT and p38a. In the resting-state complex, STEP CAT occludes a pocket on p38a formed between the MAPK insert and the C lobe that has been shown to bind allosteric signaling molecules that are known activators of the p38a cascade, such as fatty acids (Diskin et al., 2008; Nony et al., 2005; Perry et al., 2009 ). Binding of certain lipid-based molecules to this pocket has been shown to promote autophosphorylation and activation of p38a in vitro (Gills et al., 2007; Tzarum et al., 2012) . STEP regulates p38a at the site of extrasynaptic glutamate receptors, where overactivation of the kinase leads to the production of proapoptotic signals culminating in neuronal cell death (Poddar et al., 2010) . Therefore, STEP may have adapted several means to suppress p38a activity in the resting state. First, by binding strongly to the KIM binding site, STEP prevents upstream activating kinases from promiscuously binding and activating p38a. Second, by blocking access to the MAPK insert pocket, through the STEP CAT interaction, STEP can prevent the binding of allosteric signaling molecules that induce autoactivation of p38a.
The orientation of STEP CAT in the p38a:STEP resting-state complex is not conducive to dephosphorylation of the tyrosine residue in the p38a phosphorylation loop and significant rotation of STEP CAT is necessary to properly position the active site for catalysis. This domain rearrangement is evident when comparing SAXS data of the resting and active states of the p38a:STEP complex. A study conducted by Zhang et al. showed that STEP is significantly less efficient than PTPSL and HePTP at dephosphorylating p38a. The k cat for the STEP-catalyzed dephosphorylation of p38a is $20-fold lower than those for PTPSL or HePTP, showing that it is likely easier to move the flexibly tethered HePTP CAT and PTPSL CAT than moving the ''trapped'' (i.e., p38a-bound) STEP CAT (Balasu et al., 2009; Zhang et al., 2011) .
Taken together, these results provide fundamental insights into the molecular basis of p38a regulation by the neuronal KIM-PTPs. We have identified how STEP prevents promiscuous activation of p38a by blocking access to the MAPK insert pocket. Because p38a has been implicated in the pathogenesis of numerous neurological disorders, these findings could facilitate the development of new drug therapies to treat these disorders.
EXPERIMENTAL PROCEDURES
Peptide and Protein Preparation
The PTPSL KIM peptide (IGLQERRGSNVSLTLDM), STEP KIM (MGLQERR GSNVSLTLDM), and STEP KIMKIS (MGLQERRGSNVSLTLDMCTPGCNEEGFG YLVSPREESAHEYLLS) were synthesized, HPLC purified, and verified by mass spectrometry (MS) (>98% purity; Biosynthesis).
Expression and purification of unphosphorylated p38a was carried out as previously described (Francis et al., 2011a) . PTPSL (residues 332-655), PTPSL CAT (residues 361-655), STEP (residues 214-539), STEP CAT (residues 244-539), and PSChimera (PTPSL residues 332-373 with STEP residues 257-539; gene synthesized by DNA 2.0) were expressed and purified using the protocol previously described in detail for STEP CAT (Francis et al., 2013) . STEP (residues 214-539) mutants F274A/F281A, F280A/I307A, and M285A/ I307A were produced by quick-change mutagenesis.
The PTPSL KIMKIS (residues 332-373) was subcloned into a derivative of the pET28 vector that includes an N-terminal His 6 -tag and a TEV protease recognition sequence (Peti and Page, 2007) . The expression vector was transformed into BL21-(DE3) RIL E. coli cells (Invitrogen). Cultures were grown in Luria broth at 37 C with shaking at 250 rpm until reaching an optical density (OD 600 ) between 0.6 and 0.8, at which point expression was induced by the addition of 1.0 mM isopropylthio-b-D-galactoside (IPTG, final concentration). The cultures were grown for an additional 3 hr at 37 C with shaking at 250 rpm. The cells were harvested by centrifugation (6,000 3 g, 12 min, 4 C) and stored at À80 C until purification. All buffers and glassware used for purification were autoclaved prior to purification. For purification, cell pellets were resuspended in lysis buffer (50 mM Tris [pH 8.0], 500 mM NaCl, 5 mM imidazole, 0.1% Triton X-1000, and cOmplete EDTA-free protease inhibitor cocktail tablets; Roche) and lysed by high-pressure homogenization (Avestin C3 Emulsiflex). The bacterial lysate was cleared by centrifugation (35,000 3 g, 40 min, 4 C). After filtration, the supernatant was loaded onto a 5 ml HisTrap HP column (GE Healthcare) equilibrated with Buffer A (50 mM Tris [pH 8.0], 500 mM NaCl, and 5 mM imidazole). Protein was eluted from the column using a 5-500 mM imidazole gradient over 20 column Structure volumes. Purified fractions were pooled, and the His 6 -tag was removed by incubation with TEV protease during overnight dialysis in 50 mM Tris (pH 8.0), 500 mM NaCl at 4 C. The TEV protease, the His 6 -tag, and uncleaved protein were removed using a second IMAC step. Final purification was achieved using size exclusion chromatography (SEC) equilibrated in 50 mM Tris (pH 6.8), 500 mM NaCl. The molecular weight of the purified peptide was verified by electrospray-ionization MS.
All unlabeled, purified proteins were stored at À80 C until use, at which point they were thawed and equilibrated in the appropriate buffer using SEC. All labeled proteins for NMR analysis were purified within 24 hr of data acquisition and stored on ice. PTPSL KIM , STEP KIM , and STEP KIMKIS peptides were solubilized in the appropriate buffer prior to the experiment. The final protein buffer was dependent on the experiment performed. For ITC experiments, the final SEC purification was performed in ITC buffer (10 mM Tris pH 7.5, 150 mM NaCl, 0.1 mM EDTA, 0.5 mM TCEP); for NMR and SAXS experiments, the final SEC purification was performed in NMR buffer (50 mM HEPES [pH 6.8], 150 mM NaCl, 5 mM dithiothreitol).
NMR Sample Preparation
[ 2 H, 15 N]-p38a (Vogtherr et al., 2005) and [ 2 H, 15 N]-STEP were expressed in M9 media supplemented with 15 NH 4 Cl (1 g/l) in 99% D 2 O and purified as previously described. PTPSL KIM , PTPSL KIMKIS , STEP KIM , or STEP KIMKIS peptides were added to [ 2 H, 15 N]-p38a (100 mM p38a) in the following molar excesses: PTPSL KIM (1:1 and 1:8 molar ratios, p38:peptide), PTPSL KIMKIS (1:1 and 1:3 molar ratios, p38:peptide), STEP KIM (1:1, 1:3, 1:5, and 1:8 molar ratios, p38:peptide), and STEP KIMKIS (1:1, 1:3, 1:6, and 1:8 molar ratios, p38:peptide). PTPSL CAT and STEP CAT were added to [ 2 H, 15 N]-p38a (100 mM p38a) in a twofold molar excess (0.1 mM [ 2 H, 15 N]-p38a:0.2 mM PTPSL CAT or STEP CAT ). For p38a:KIM-PTP complex formation, [ 2 H, 15 N]-p38a was incubated with either PTPSL, STEP, or PSChimera (1:1 molar ratio) on ice for 45 min and purified using SEC (Superdex 75 26/60, NMR buffer). Each p38a:KIM-PTP complex elutes at the position expected for the p38a:KIM-PTP heterodimer. Each [ 2 H, 15 N]-p38a:KIM-PTP complex was concentrated to 0.1 mM and stored on ice (<8 hr) until NMR data acquisition. For the p38a:[ 2 H, 15 N]-STEP complex formation, [ 2 H, 15 N]-STEP was incubated with p38a (1:1 molar ratio) on ice for 45 min and purified using SEC (Superdex 75 26/60, NMR buffer). The p38a:[ 2 H, 15 N]-STEP complex was concentrated to 0.1 mM and stored on ice (<2 hr) until NMR data acquisition. A 2D [ 1 H, 15 N]-TROSY spectrum was recorded for all samples described above. All NMR experiments were performed at 298 K on a Bruker Advance 800 MHz spectrometer equipped with a TCI HCN z-gradient cryoprobe. NMR samples were prepared in NMR buffer in 90% H 2 O/10% D 2 O. The NMR spectra were processed with Topspin 2.1/ 3.0/3.1 (Bruker) and analyzed using CARA (http://cara.nmr.ch).
Chemical Shift Perturbation Studies
The p38a:STEP KIM and p38a: PTPSL KIM peptide titration series (1:1, 1:3, 1:5, and 1:8 ratios, p38a:STEP KIM ) were used to follow chemical shift changes in p38a upon peptide or protein binding. Nearly all peaks showed fast exchange and thus could be easily tracked. The observed trajectory of each peak was applied to the analysis of the KIMKIS peptides (PTPSL KIMKIS and STEP KIMKIS ) and the full-length complexes (PTPSL, STEP, and PSChimera), allowing for high certainty of peak assignments of p38a in the bound conformations. All chemical shift differences (Dd) were calculated using
To allow for direct comparison across all CSP experiments, we used identical cut-off CSPs as in the HePTP NMR experiments; small CSP 0.07-0.103 ppm, medium CSP 0.104-0.131 ppm, and large CSP R0.132 (Francis et al., 2011a) .
HADDOCK Calculations
HADDOCK was used to dock p38a and STEP using ambiguous NMR-derived restraints. p38a (PBDID 1P38) and STEP (PBDID 2BIJ) were used as starting input. Active residues were defined as those that undergo a CSP and have high solvent accessibility in the unbound protein structure (p38a residues: 177, 179, 183, 222, 248, 254, and 256; STEP residues: 263, 268, 269, 274, 277, 278, 279, 281, 282, 285, 286, 294, 306, 307, 377, 378, 379, 516, 517, and 518) . Passive residues have a CSP but low solvent accessibility (p38a residues : 190, 195, 247, 255, and 328; STEP residues: 276, 280, 350, 353, 376, 380, 478, 479, 482, 520, and 525) . CSPs were the only experimental restraint type used in the HADDOCK calculation and default settings were used for all docking steps, as used by the easy interface of the HADDOCK web server (http://haddock.science.uu.nl/enmr/services/HADDOCK).
Isothermal Titration Calorimetry
ITC experiments were performed at 25 C using a VP-ITC microcalorimeter (Microcal). Titrant (10 ml per injection) was injected into the sample cell over a period of 20 s with a 250 s interval between titrations to allow for complete equilibration and baseline recovery. Twenty-eight injections were delivered during each experiment, and the solution in the sample cell was stirred at 307 rpm to ensure rapid mixing. To determine the thermodynamic parameters (DH, DS, and DG) and binding constants (K) of the p38a:PTPSL KIM , p38a:PTPSL, and p38a:STEP interactions, PTPSL KIM , PTPSL, and STEP were titrated into the p38a. To determine the same parameters for the p38a: STEP KIM , p38a:PTPSL KIMKIS , p38a:STEP KIMKIS , and p38a:PSChimera interaction, p38a was titrated into the protein. For all titrations the concentrations were slightly varied to ensure independence of the K d from the protein/peptide concentrations. Data were analyzed with a one-site binding model assuming a binding stoichiometry of 1:1 using Origin 7.0 software. A nonlinear leastsquares algorithm and the titrant and sample cell concentrations were used to fit the heat flow per injection to an equilibrium binding equation, providing values of the stoichiometry (n), change in enthalpy (DH), and binding constant (K). All data were repeated in triplicate.
Small-Angle X-Ray Scattering
For the resting-state p38a: PTPSL and p38a:STEP complexes, purified, unphosphorylated p38a was incubated in a 1:1 molar ratio with purified PTPSL 331-655 and/or purified STEP 214-539 on ice for 30 min and the complexes purified using SEC (Superdex 75 26/60, NMR buffer). To form the active-state complex of p38a:STEP, purified, dually phosphorylated p38a was incubated in a 1:1 molar ratio with purified STEP 214-539 T306D/C472S on ice for 30 min and the complex was purified using SEC (Superdex 75 26/60, NMR buffer). For p38a:PTPSL, data were collected on samples at 0.4, 0.8, 1.6, 2.3, and 4.0 mg/ml. For resting-state p38a:STEP, data were collected on samples at 1.0, 2.0, and 4.0 mg/ml. For active-state p38a:STEP, data were collected on samples at 0.8, 3.3, and 6.1 mg/ml. All samples were prepared within 48 hr of data acquisition and stored on ice at 4 C. All samples were filtered (0.02 mM filter, Whatman) immediately prior to data collection. All data were recorded at beamline X9 at the National Synchrotron Light Source (NSLS) using a Dectris pilatus 300k (p38a:PTPSL and active-state p38a:STEP; 3.4 m distance from the sample for SAXS) or a MarCCD 165 (resting-state p38a:STEP; 3.4 m distance from the sample for SAXS) and a Photonic Science CCD (0.47 m from the sample for WAXS) detector. Twenty microliters of sample was continuously flowed through a 1 mm diameter capillary and exposed to an X-ray beam for 30 s (p38a:PTPSL), 60 s (active-state p38a:STEP), or 180 s (resting-state p38a:STEP). Normalization for beam intensity, buffer subtraction, and merging of the data from both detectors was carried out using PRIMUS (Konarev et al., 2003) . A Guinier approximation, I(q) = I(0)exp(Àq 2 R g 2 / 3), where a plot of ln[I(q)] and q 2 is linear for q < 1.3/R g , was performed on at least four independent scattering trials and averaged to determine the radius of gyration. The linearity of the Guinier region and the intensity at zero scattering angle, I(0), were used to validate that all samples were monodisperse in solution. I(0)/c, where c is concentration, was consistent for all measurements for a single complex. GNOM (Svergun, 1992) was used to determine the pair-distribution function, P(r), for each complex. Twenty-four envelopes were generated for each complex using GASBOR and were aligned and averaged using the DAMAVER program suite . 
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